Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Turkish Journal of Medical Sciences|November 25, 2020
Gemcitabine, dexamethasone and cisplatin (GDP) is an effective and well-tolerated mobilization regimen for relapsed and refractory lymphoma: a single center experienceHikmettullah Batgi, Semih Başcı, Mehmet Sinan Dal, et al.
Leukemia Research|September 4, 2021
Factors affecting survival in elderly patients with diffuse large B-Cell lymphomaBahar Uncu Ulu, Tuğçe Nur Yiğenoğlu, Semih Başcı, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|January 27, 2016
Primary central nervous system lymphoma in daily practice and the role of autologous stem cell transplantation in relapsed disease: A retrospective multicenter studyMehmet Ali Erkurt, Ilhami Berber, Emre Tekgündüz, et al.
Internal and Emergency Medicine|June 10, 2021
Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancersSemih Başcı, Naim Ata, Fevzi Altuntaş, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|February 23, 2016
Hematopoietic cell transplantation activity of Turkey in 2014: Ongoing increase in HCT ratesEmre Tekgündüz, İrfan Şencan, Arif Kapuağası, et al.
Turkish Journal of Medical Sciences|May 6, 2021
COVID-19 clinical course and blood groups: Turkish population-based studyMehmet Sinan Dal, Naim Ata, Fevzi Altuntaş, et al.
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|February 21, 2020
Patterns of Hydroxyurea Prescription and Use in Routine Clinical Management of Polycythemia Vera: A Multicenter Chart Review StudyYahya Büyükaşık, Rıdvan Ali, Mehmet Turgut, et al.
Journal of Clinical Medicine|January 28, 2026
Real-World Utilization of Midostaurin in Combination with Intensive Chemotherapy for Patients with FLT3 Mutated Acute Myeloid Leukemia: A Multicenter StudySema Seçilmiş, Sibel Kabukçu Hacıoğlu, Fehmi Hindilerden, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|August 29, 2020
Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitorsSemih Başcı, Naim Ata, Fevzi Altuntaş, et al.
Pageof 9